A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers
Clinical trial NCT05548387 · COMPLETED
Trial details
- NCT number
- NCT05548387
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-02
- Primary completion
- 2022-11-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.